WAFERLOGIX Trademark

Trademark Overview


On Wednesday, July 19, 2023, a trademark application was filed for WAFERLOGIX with the United States Patent and Trademark Office. The USPTO has given the WAFERLOGIX trademark a serial number of 79377279. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 24, 2024. This trademark is owned by iX Biopharma Ltd. The WAFERLOGIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and nutraceutical preparations for therapeutic or medical purposes in the form of dissolvable wafers that facilitate the delivery of a wide variety of pharmaceutical and nutraceutical actives for the treatment of viral diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, gastrointestinal diseases, endocrine and metabolic diseases, autoimmune diseases, cancer, genetic disorders, musculoskeletal diseases, renal (kidney) diseases, skin diseases, haematological diseases, psychiatric disorders, immunodeficiency disorders, eye and ear disorders, reproductive and gynaecological diseases, oral and dental diseases, allergic diseases, rare and orphan diseases, nutritional diseases, rheumatic diseases, vascular diseases, liver diseases, urinary tract diseases, and sleep disorders

General Information


Serial Number79377279
Word MarkWAFERLOGIX
Filing DateWednesday, July 19, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2024

Trademark Statements


Goods and ServicesPharmaceutical and nutraceutical preparations for therapeutic or medical purposes in the form of dissolvable wafers that facilitate the delivery of a wide variety of pharmaceutical and nutraceutical actives for the treatment of viral diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, gastrointestinal diseases, endocrine and metabolic diseases, autoimmune diseases, cancer, genetic disorders, musculoskeletal diseases, renal (kidney) diseases, skin diseases, haematological diseases, psychiatric disorders, immunodeficiency disorders, eye and ear disorders, reproductive and gynaecological diseases, oral and dental diseases, allergic diseases, rare and orphan diseases, nutritional diseases, rheumatic diseases, vascular diseases, liver diseases, urinary tract diseases, and sleep disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameiX Biopharma Ltd
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Party NameiX Biopharma Ltd
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events


Event DateEvent Description
Thursday, August 24, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 12, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 12, 2024REFUSAL PROCESSED BY MPU
Thursday, April 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 29, 2023APPLICATION FILING RECEIPT MAILED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Monday, March 25, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 26, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 8, 2024REFUSAL PROCESSED BY IB
Tuesday, June 11, 2024FINAL REFUSAL WRITTEN
Thursday, April 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 11, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2024FINAL REFUSAL E-MAILED
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, July 30, 2024ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Tuesday, July 30, 2024ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Thursday, October 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 2, 2024ASSIGNED TO EXAMINER
Monday, December 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 30, 2024NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Thursday, October 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 17, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 22, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 22, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 24, 2024PUBLISHED FOR OPPOSITION